APOB and metabolic syndrome: In this study, 39.0%, 3.5%, and 0.4% of subjects who were not identified as having dyslipidemia based on traditional lipid test results were newly recognized as having a high-risk for CVD when using ApoB cutoffs of 100 mg/dL, 130 mg/dL, and 145 mg/dL, respectively.